Literature DB >> 22730212

MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells.

Qian Wei1, Yi-Xuan Li, Min Liu, Xin Li, Hua Tang.   

Abstract

MicroRNAs are a class of small endogenous noncoding RNAs that function as post-transcriptional regulators. Tumor protein p53-induced nuclear protein 1 (TP53INP1) is a p53 target gene and is a major player in the stress response. Here, we identified TP53INP1 as a target of miR-17-5p. miR-17-5p suppressed cell growth and promoted apoptosis of cervical cancer cells, whereas the effects of TP53INP1 were opposite, and ectopic expression of TP53INP1 counteracted the suppression of cell growth caused by miR-17-5p. The same correlations between miR-17-5p and TP53INP1 were observed in cervical cancer tissues. Together, these results indicated that miR-17-5p functions as a tumor suppressor in cervical cancer cells by targeting TP53INP1.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22730212     DOI: 10.1002/iub.1051

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  42 in total

Review 1.  A network-biology perspective of microRNA function and dysfunction in cancer.

Authors:  Cameron P Bracken; Hamish S Scott; Gregory J Goodall
Journal:  Nat Rev Genet       Date:  2016-10-31       Impact factor: 53.242

Review 2.  Epigenetics and cervical cancer: from pathogenesis to therapy.

Authors:  Jinchuan Fang; Hai Zhang; Sufang Jin
Journal:  Tumour Biol       Date:  2014-02-20

3.  LncRNA SNHG15 Knockdown Protects Against OGD/R-Induced Neuron Injury by Downregulating TP53INP1 Expression via Binding to miR-455-3p.

Authors:  Yun Fan; Lihong Wei; Sanjun Zhang; Xueyun Song; Jiaqing Yang; Xiaoxia He; Xianzhao Zheng
Journal:  Neurochem Res       Date:  2021-02-02       Impact factor: 3.996

4.  Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer.

Authors:  A C West; K Tang; H Tye; L Yu; N Deng; M Najdovska; S J Lin; J J Balic; E Okochi-Takada; P McGuirk; B Keogh; W McCormack; P S Bhathal; M Reilly; M Oshima; T Ushijima; P Tan; B J Jenkins
Journal:  Oncogene       Date:  2017-05-08       Impact factor: 9.867

5.  MicroRNA-92a promotes cell viability and invasion in cervical cancer via directly targeting Dickkopf-related protein 3.

Authors:  Shengtian Luo; Na Li; Shaohua Yu; Lichun Chen; Chunying Liu; Jiawei Rong
Journal:  Exp Ther Med       Date:  2017-06-13       Impact factor: 2.447

6.  miR-155 is associated with the leukemogenic potential of the class IV granulocyte colony-stimulating factor receptor in CD34⁺ progenitor cells.

Authors:  HaiJiao Zhang; Lilia Goudeva; Stephan Immenschuh; Axel Schambach; Julia Skokowa; Britta Eiz-Vesper; Rainer Blasczyk; Constança Figueiredo
Journal:  Mol Med       Date:  2015-04-09       Impact factor: 6.354

Review 7.  Stabilization of miRNAs in esophageal cancer contributes to radioresistance and limits efficacy of therapy.

Authors:  Akshay Malhotra; Uttam Sharma; Shyamly Puhan; Naga Chandra Bandari; Anjali Kharb; P P Arifa; Lovlesh Thakur; Hridayesh Prakash; Karen M Vasquez; Aklank Jain
Journal:  Biochimie       Date:  2018-10-13       Impact factor: 4.079

Review 8.  MicroRNAs in gynecological cancers: Small molecules with big implications.

Authors:  Sanjeev K Srivastava; Aamir Ahmad; Haseeb Zubair; Orlandric Miree; Seema Singh; Rodney P Rocconi; Jennifer Scalici; Ajay P Singh
Journal:  Cancer Lett       Date:  2017-05-24       Impact factor: 8.679

9.  MiR-345 suppresses proliferation, migration and invasion by targeting Smad1 in human prostate cancer.

Authors:  Qi-guang Chen; Wei Zhou; Tao Han; Shu-qi Du; Zhen-hua Li; Zhe Zhang; Guang-yi Shan; Chui-ze Kong
Journal:  J Cancer Res Clin Oncol       Date:  2015-07-31       Impact factor: 4.553

10.  Prognostic significance of serum miR-17-5p in lung cancer.

Authors:  Qun Chen; Qing Si; Song Xiao; Qiang Xie; Jiangping Lin; Chenhui Wang; Lizhou Chen; Qiaolin Chen; Lin Wang
Journal:  Med Oncol       Date:  2012-12-24       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.